Terms: = Germ cell tumor AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
48 results:
1. Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma.
Sakunrangsit N; Khuisangeam N; Inthanachai T; Yodsurang V; Taechawattananant P; Suppipat K; Tawinwung S
Cancer Immunol Immunother; 2024 Apr; 73(6):98. PubMed ID: 38619641
[TBL] [Abstract] [Full Text] [Related]
2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
3. A Population of tumor-Infiltrating CD4+ T cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.
Mitra A; Thompson B; Strange A; Amato CM; Vassallo M; Dolgalev I; Hester-McCullough J; Muramatsu T; Kimono D; Puranik AS; Weber JS; Woods D
Clin Cancer Res; 2023 Oct; 29(20):4242-4255. PubMed ID: 37505479
[TBL] [Abstract] [Full Text] [Related]
4. IL-7R licenses a population of epigenetically poised memory CD8
Micevic G; Daniels A; Flem-Karlsen K; Park K; Talty R; McGeary M; Mirza H; Blackburn HN; Sefik E; Cheung JF; Hornick NI; Aizenbud L; Joshi NS; Kluger H; Iwasaki A; Bosenberg MW; Flavell RA
Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2304319120. PubMed ID: 37459511
[TBL] [Abstract] [Full Text] [Related]
5. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.
Congur I; Koni E; Onat OE; Tokcaer Keskin Z
PeerJ; 2023; 11():e15250. PubMed ID: 37096065
[TBL] [Abstract] [Full Text] [Related]
6. Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure.
Qu R; Kluger Y; Yang J; Zhao J; Hafler DA; Krause DS; Bersenev A; Bosenberg M; Hurwitz M; Lucca L; Kluger HM
Mol Cancer; 2022 Dec; 21(1):219. PubMed ID: 36514045
[TBL] [Abstract] [Full Text] [Related]
7. Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
Khushalani NI; Vassallo M; Goldberg JD; Eroglu Z; Kim Y; Cao B; Ferguson R; Monson KR; Kirchhoff T; Amato CM; Burke P; Strange A; Monk E; Gibney GT; Kudchadkar R; Markowitz J; Brohl AS; Pavlick A; Richards A; Woods DM; Weber J
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450385
[TBL] [Abstract] [Full Text] [Related]
8. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma.
DiVincenzo MJ; Schwarz E; Ren C; Barricklow Z; Moufawad M; Yu L; Fadda P; Angell C; Sun S; Howard JH; Chung C; Slingluff C; Gru AA; Kendra K; Carson WE
J Invest Dermatol; 2023 Apr; 143(4):630-638.e3. PubMed ID: 36202232
[TBL] [Abstract] [Full Text] [Related]
9. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
Front Immunol; 2022; 13():914108. PubMed ID: 36032150
[TBL] [Abstract] [Full Text] [Related]
10. Calcipotriol, a synthetic Vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activation.
Kim H; Kim J; Sa JK; Ryu BK; Park KJ; Kim J; Ha H; Park Y; Shin MH; Kim J; Lee H; Kim D; Lee K; Jang B; Lee KM; Kang SH
Biomed Pharmacother; 2022 Oct; 154():113553. PubMed ID: 35994815
[TBL] [Abstract] [Full Text] [Related]
11. Interleukin-7 regulates cd127 expression and promotes CD8
He H; Qiao B; Guo S; Cui H; Zhang Z; Qin J
BMC Immunol; 2022 Jul; 23(1):35. PubMed ID: 35850640
[TBL] [Abstract] [Full Text] [Related]
12. Analyzing Prognostic Hub Genes in the Microenvironment of Cutaneous Melanoma by Computer Integrated Bioinformatics.
Li G; Zhang J; Liu Y; Cheng X; Sun K; Hong W; Sha K
Comput Intell Neurosci; 2022; 2022():4493347. PubMed ID: 35300397
[TBL] [Abstract] [Full Text] [Related]
13. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis.
Zhang C; Dang D; Cong L; Sun H; Cong X
Cancer Med; 2021 Jul; 10(14):4710-4720. PubMed ID: 34159752
[TBL] [Abstract] [Full Text] [Related]
14. Induction of T helper 17 cell response by interleukin-7 in patients with primary cutaneous melanoma.
He H; Qiao B; Guo S; Cui H; Li N; Liu H; Qin J; He J; Yang X; Xue W; Wang Y
Melanoma Res; 2021 Aug; 31(4):328-337. PubMed ID: 34054059
[TBL] [Abstract] [Full Text] [Related]
15. Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid tumors.
Grigoriou M; Banos A; Hatzioannou A; Kloetgen A; Kouzis P; Aggouraki D; Zakopoulou R; Bamias G; Kassi E; Mavroudis D; Bamias A; Boumpas DT; Tsirigos A; Gogas H; Alissafi T; Verginis P
Cancer Immunol Res; 2021 Jul; 9(7):726-734. PubMed ID: 33820810
[TBL] [Abstract] [Full Text] [Related]
16. Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.
Novik AV; Protsenko SA; Baldueva IA; Berstein LM; Anisimov VN; Zhuk IN; Semenova AI; Latipova DK; Tkachenko EV; Semiglazova TY
Oncologist; 2021 May; 26(5):364-e734. PubMed ID: 33749049
[TBL] [Abstract] [Full Text] [Related]
17. tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome.
González-Tablas Pimenta M; Otero Á; Arandia Guzman DA; Pascual-Argente D; Ruíz Martín L; Sousa-Casasnovas P; García-Martin A; Roa Montes de Oca JC; Villaseñor-Ledezma J; Torres Carretero L; Almeida M; Ortiz J; Nieto A; Orfao A; Tabernero MD
Brain Pathol; 2021 Mar; 31(2):365-380. PubMed ID: 33314398
[TBL] [Abstract] [Full Text] [Related]
18. Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes.
Woods DM; Laino AS; Winters A; Alexandre J; Freeman D; Rao V; Adavani SS; Weber JS; Chattopadhyay PK
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369447
[TBL] [Abstract] [Full Text] [Related]
19. An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.
Chen MH; Chou WC; Hsiao CF; Jiang SS; Tsai HJ; Liu YC; Hsu C; Shan YS; Hung YP; Hsich CH; Chiu CH; Liu TC; Cho SF; Liu TW; Chao Y
Oncologist; 2020 May; 25(5):e782-e788. PubMed ID: 31852810
[TBL] [Abstract] [Full Text] [Related]
20. Decline of programmed death-1-positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade.
Gambichler T; Schröter U; Höxtermann S; Susok L; Stockfleth E; Becker JC
Br J Dermatol; 2020 May; 182(5):1214-1220. PubMed ID: 31361026
[TBL] [Abstract] [Full Text] [Related]
[Next]
